Remove Innovation Remove Kidney Disease Remove Patient Care
article thumbnail

The Cardiometabolic Event of the Year: What to Expect at the 19th Annual Cardiometabolic Health Congress (CMHC) 

Cardiometabolic Health Congress

For 19 years, the Cardiometabolic Health Congress (CMHC) has worked towards a vision of a better future for clinicians, patients, and the entire health sector. This fall, we come together for the largest and most innovative cardiometabolic event in honor of the legacy of Dr. George L. The future of care demands a holistic approach.

Education 100
article thumbnail

2024’s Mid-Year Review: FDA-Approved Cardiorenal Metabolic Drugs and Devices 

Cardiometabolic Health Congress

Staying informed about these cutting-edge developments is critical for providing exceptional patient care. Join us as we examine the landmark approvals that are revolutionizing patient outcomes. Join us at the 19th Annual CMHC , where we’ll delve deeper into these innovations and their implications for clinical practice.

article thumbnail

19th Annual Cardiometabolic Health Congress: Honoring the Life and Legacy of CMHC Co-Chair Dr. George L. Bakris

Cardiometabolic Health Congress

With his support, CMHC has championed a vision of a brighter future for clinicians, patients, and the entire healthcare sector. This October, we gather for the largest and most innovative cardiometabolic event, honoring Dr. Bakris’ profound impact on our community. Contact Data Megan Magana, Sr.

CME 72
article thumbnail

Creative Alliances in Cardiorenal Metabolic Management: A Game Changer (Part 1) 

Cardiometabolic Health Congress

These interconnected diseases pose a significant global health threat, with cardiovascular diseases alone accounting for one-third of all deaths worldwide , according to the World Health Organization. We need a comprehensive and innovative approach to cardiorenal metabolic management and risk reduction to address this challenge.

article thumbnail

Top 10 Cardiac Diagnosis Trends in 2024

GEMMS

Additionally, integrating smart point-of-care tests (POCTs) and digital health applications has notably improved clinical diagnosis, streamlining the monitoring and management of cardiac health in home and remote healthcare settings. Genetic testing and DNA sequencing improve the accuracy of predicting heart disease risk.